FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:2285-2293 June 5, 2003 Number 23 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Ritz, E. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background In the present study, we aimed to determine the frequency of a significant reduction in urinary albumin excretion and factors affecting such reduction in patients with type 1 diabetes and microalbuminuria.

Methods The study included 386 patients with persistent microalbuminuria, indicated by repeated measurements of urinary albumin excretion (estimated on the basis of albumin-to-creatinine ratios) in the range of 30 to 299 µg per minute during an initial two-year evaluation period. Subsequent measurements during the next six years were grouped into two-year periods, averaged, and analyzed for regression of microalbuminuria, which was defined as a 50 percent reduction in urinary albumin excretion from one two-year period to the next.

Results Regression of microalbuminuria was frequent, with a six-year cumulative incidence of 58 percent (95 percent confidence interval, 52 to 64 percent). The use of angiotensin-converting–enzyme inhibitors was not associated with the regression of microalbuminuria. However, microalbuminuria of short duration, salutary levels of glycosylated hemoglobin (less than 8 percent), low systolic blood pressure (less than 115 mm Hg), and low levels of both cholesterol and triglycerides (less than 198 mg per deciliter [5.12 mmol per liter] and 145 mg per deciliter [1.64 mmol per liter], respectively) were independently associated with the regression of microalbuminuria. Patients with salutary levels of all modifiable factors had a hazard ratio for regression of 3.0 (95 percent confidence interval, 1.5 to 6.0), as compared with patients with no salutary levels of any modifiable factor.

Conclusions Frequent regression of microalbuminuria in patients with type 1 diabetes indicates that elevated urinary albumin excretion does not imply inexorably progressive nephropathy. Identification of the multiple determinants of the regression of microalbuminuria has implications for current theories about the mechanisms of early diabetic nephropathy.

Source Information

From the Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center (B.A.P., L.H.F., K.H.S., J.H.W., A.S.K.); the Department of Medicine, Harvard Medical School (B.A.P., D.M.F., A.S.K.); the Massachusetts General Hospital Biostatistics Center (D.M.F.); and the Harvard School of Public Health (D.M.F., J.H.W., A.S.K.) — all in Boston.

Address reprint requests to Dr. Krolewski at the Section on Genetics and Epidemiology, Joslin Diabetes Center, 1 Joslin Pl., Boston, MA 02215, or at andrzej.krolewski{at}joslin.harvard.edu.

Full Text of this Article

Related Letters:

Regression of Microalbuminuria in Type 1 Diabetes
Friedman A. N., Catena C., Novello M., Sechi L. A., Hohenadel D., Bode H., van der Woude F. J., Zerbini G., Perkins B. A., Warram J. H., Krolewski A. S.
Extract | Full Text | PDF  
N Engl J Med 2003; 349:906-908, Aug 28, 2003. Correspondence

This article has been cited by other articles:

• Oudit, G. Y., Liu, G. C., Zhong, J., Basu, R., Chow, F. L., Zhou, J., Loibner, H., Janzek, E., Schuster, M., Penninger, J. M., Herzenberg, A. M., Kassiri, Z., Scholey, J. W. (2010). Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy. Diabetes 59: 529-538 [Abstract] [Full Text]  
• Kosugi, T., Heinig, M., Nakayama, T., Matsuo, S., Nakagawa, T. (2010). eNOS Knockout Mice with Advanced Diabetic Nephropathy Have Less Benefit from Renin-Angiotensin Blockade than from Aldosterone Receptor Antagonists. Am. J. Pathol. 176: 619-629 [Abstract] [Full Text]  
• Marcovecchio, M. L., Tossavainen, P. H., Dunger, D. B. (2010). Prevention and treatment of microvascular disease in childhood type 1 diabetes. Br Med Bull 0: ldp053v1-ldp053 [Abstract] [Full Text]  
• Jia, W., Gao, X., Pang, C., Hou, X., Bao, Y., Liu, W., Wang, W., Zuo, Y., Gu, H., Xiang, K. (2009). Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS). Nephrol Dial Transplant 24: 3724-3731 [Abstract] [Full Text]  
• American Association of Diabetes Educators, (2009). Diabetic Kidney Disease. The Diabetes Educator 35: 53S-56S [Full Text]  
• Merchant, M. L., Perkins, B. A., Boratyn, G. M., Ficociello, L. H., Wilkey, D. W., Barati, M. T., Bertram, C. C., Page, G. P., Rovin, B. H., Warram, J. H., Krolewski, A. S., Klein, J. B. (2009). Urinary Peptidome May Predict Renal Function Decline in Type 1 Diabetes and Microalbuminuria. J. Am. Soc. Nephrol. 20: 2065-2074 [Abstract] [Full Text]  
• Pezzolesi, M. G., Poznik, G. D., Mychaleckyj, J. C., Paterson, A. D., Barati, M. T., Klein, J. B., Ng, D. P.K., Placha, G., Canani, L. H., Bochenski, J., Waggott, D., Merchant, M. L., Krolewski, B., Mirea, L., Wanic, K., Katavetin, P., Kure, M., Wolkow, P., Dunn, J. S., Smiles, A., Walker, W. H., Boright, A. P., Bull, S. B., the DCCT/EDIC Research Group, , Doria, A., Rogus, J. J., Rich, S. S., Warram, J. H., Krolewski, A. S. (2009). Genome-Wide Association Scan for Diabetic Nephropathy Susceptibility Genes in Type 1 Diabetes. Diabetes 58: 1403-1410 [Abstract] [Full Text]  
• Loredana Marcovecchio, M., Neil Dalton, R., Toby Prevost, A., Acerini, C. L., Barrett, T. G., Cooper, J. D., Edge, J., Neil, A., Shield, J., Widmer, B., Todd, J. A., Dunger, D. B. (2009). Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes. Diabetes Care 32: 658-663 [Abstract] [Full Text]  
• Khavandi, K., Greenstein, A. S., Sonoyama, K., Withers, S., Price, A., Malik, R. A., Heagerty, A. M. (2009). Myogenic tone and small artery remodelling: insight into diabetic nephropathy. Nephrol Dial Transplant 24: 361-369 [Full Text]  
• Schernthaner, G. (2009). Kidney disease in diabetology: lessons from 2008. Nephrol Dial Transplant 24: 396-399 [Full Text]  
• Maeda, S. (2008). Review: Genetics of diabetic nephropathy. Ther Adv Cardiovasc Dis 2: 363-371 [Abstract]  
• Zhou, J., Chen, X., Xie, Y., Li, J., Yamanaka, N., Tong, X. (2008). A differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases. Nephrol Dial Transplant 23: 1940-1945 [Abstract] [Full Text]  
• Rosolowsky, E. T., Ficociello, L. H., Maselli, N. J., Niewczas, M. A., Binns, A. L., Roshan, B., Warram, J. H., Krolewski, A. S. (2008). High-Normal Serum Uric Acid Is Associated with Impaired Glomerular Filtration Rate in Nonproteinuric Patients with Type 1 Diabetes. CJASN 3: 706-713 [Abstract] [Full Text]  
• Wolkow, P. P., Niewczas, M. A., Perkins, B., Ficociello, L. H., Lipinski, B., Warram, J. H., Krolewski, A. S. (2008). Association of Urinary Inflammatory Markers and Renal Decline in Microalbuminuric Type 1 Diabetics. J. Am. Soc. Nephrol. 19: 789-797 [Abstract] [Full Text]  
• Amin, R., Widmer, B., Prevost, A T., Schwarze, P., Cooper, J., Edge, J., Marcovecchio, L., Neil, A., Dalton, R N., Dunger, D. B (2008). Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ 336: 697-701 [Abstract] [Full Text]  
• Tarnow, L., Groop, P.-H., Hadjadj, S., Kazeem, G., Cambien, F., Marre, M., Forsblom, C., Parving, H.-H., Tregouet, D., Thevard, A., Farrall, M., Gut, I., Gauguier, D., Cox, R., Matsuda, F., Lathrop, M., Vionnet, N., for the EURAGEDIC Consortium, (2008). European rational approach for the genetics of diabetic complications EURAGEDIC: patient populations and strategy. Nephrol Dial Transplant 23: 161-168 [Abstract] [Full Text]  
• Maahs, D. M., Snively, B. M., Bell, R. A., Dolan, L., Hirsch, I., Imperatore, G., Linder, B., Marcovina, S. M., Mayer-Davis, E. J., Pettitt, D. J., Rodriguez, B. L., Dabelea, D. (2007). Higher Prevalence of Elevated Albumin Excretion in Youth With Type 2 Than Type 1 Diabetes: The SEARCH for Diabetes in Youth Study. Diabetes Care 30: 2593-2598 [Abstract] [Full Text]  
• Roy, M. S., Affouf, M., Roy, A. (2007). Six-Year Incidence of Proteinuria in Type 1 Diabetic African Americans. Diabetes Care 30: 1807-1812 [Abstract] [Full Text]  
• The Shiga Microalbuminuria Reduction Trial (SMART), (2007). Reduction of Microalbuminuria in Patients With Type 2 Diabetes: The Shiga Microalbuminuria Reduction Trial (SMART). Diabetes Care 30: 1581-1583 [Full Text]  
• Araki, S.-i., Haneda, M., Koya, D., Hidaka, H., Sugimoto, T., Isono, M., Isshiki, K., Chin-Kanasaki, M., Uzu, T., Kashiwagi, A. (2007). Reduction in Microalbuminuria as an Integrated Indicator for Renal and Cardiovascular Risk Reduction in Patients With Type 2 Diabetes. Diabetes 56: 1727-1730 [Abstract] [Full Text]  
• Ficociello, L. H., Perkins, B. A., Silva, K. H., Finkelstein, D. M., Ignatowska-Switalska, H., Gaciong, Z., Cupples, L. A., Aschengrau, A., Warram, J. H., Krolewski, A. S. (2007). Determinants of Progression from Microalbuminuria to Proteinuria in Patients Who Have Type 1 Diabetes and Are Treated with Angiotensin-Converting Enzyme Inhibitors. CJASN 2: 461-469 [Abstract] [Full Text]  
• Perkins, B. A., Ficociello, L. H., Ostrander, B. E., Silva, K. H., Weinberg, J., Warram, J. H., Krolewski, A. S. (2007). Microalbuminuria and the Risk for Early Progressive Renal Function Decline in Type 1 Diabetes. J. Am. Soc. Nephrol. 18: 1353-1361 [Abstract] [Full Text]  
• de Boer, I. H., Steffes, M. W. (2007). Glomerular Filtration Rate and Albuminuria: Twin Manifestations of Nephropathy in Diabetes. J. Am. Soc. Nephrol. 18: 1036-1037 [Full Text]  
• Brantsma, A. H., Atthobari, J., Bakker, S. J.L., de Zeeuw, D., de Jong, P. E., Gansevoort, R. T., for the PREVEND Study Group, (2007). What Predicts Progression and Regression of Urinary Albumin Excretion in the Nondiabetic Population?. J. Am. Soc. Nephrol. 18: 637-645 [Abstract] [Full Text]  
• de Boer, I. H., Sibley, S. D., Kestenbaum, B., Sampson, J. N., Young, B., Cleary, P. A., Steffes, M. W., Weiss, N. S., Brunzell, J. D., for the Diabetes Control and Complications Trial/E, (2007). Central Obesity, Incident Microalbuminuria, and Change in Creatinine Clearance in the Epidemiology of Diabetes Interventions and Complications Study. J. Am. Soc. Nephrol. 18: 235-243 [Abstract] [Full Text]  
• Conway, B. R., Savage, D. A., Peter Maxwell, A. (2006). Identifying genes for diabetic nephropathy--current difficulties and future directions. Nephrol Dial Transplant 21: 3012-3017 [Full Text]  
• Rodriguez-Yanez, M., Castellanos, M., Blanco, M., Millan, M., Nombela, F., Sobrino, T., Lizasoain, I., Leira, R., Serena, J., Davalos, A., Castillo, J. (2006). Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke.. Neurology 67: 1172-1177 [Abstract] [Full Text]  
• Rossing, P., Parving, H.-H., de Zeeuw, D. (2006). Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?. Nephrol Dial Transplant 21: 2354-2357 [Full Text]  
• Zerbini, G., Bonfanti, R., Meschi, F., Bognetti, E., Paesano, P. L., Gianolli, L., Querques, M., Maestroni, A., Calori, G., Del Maschio, A., Fazio, F., Luzi, L., Chiumello, G. (2006). Persistent Renal Hypertrophy and Faster Decline of Glomerular Filtration Rate Precede the Development of Microalbuminuria in Type 1 Diabetes. Diabetes 55: 2620-2625 [Abstract] [Full Text]  
• de Jong, P. E., Curhan, G. C. (2006). Screening, Monitoring, and Treatment of Albuminuria: Public Health Perspectives. J. Am. Soc. Nephrol. 17: 2120-2126 [Abstract] [Full Text]  
• Najafian, B., Crosson, J. T., Kim, Y., Mauer, M. (2006). Glomerulotubular Junction Abnormalities Are Associated with Proteinuria in Type 1 Diabetes. J. Am. Soc. Nephrol. 17: S53-S60 [Abstract] [Full Text]  
• Caramori, M. L., Fioretto, P., Mauer, M. (2006). Enhancing the Predictive Value of Urinary Albumin for Diabetic Nephropathy. J. Am. Soc. Nephrol. 17: 339-352 [Abstract] [Full Text]  
• Briggs, J. P., Hostetter, T. H. (2006). Opening Words for CJASN. CJASN 1: 3-5 [Full Text]  
• Sale, M. M., Freedman, B. I. (2006). Genetic determinants of albuminuria and renal disease in diabetes mellitus. Nephrol Dial Transplant 21: 13-16 [Full Text]  
• Nosadini, R., Velussi, M., Brocco, E., Abaterusso, C., Carraro, A., Piarulli, F., Morgia, G., Satta, A., Faedda, R., Abhyankar, A., Luthman, H., Tonolo, G. (2006). Increased Renal Arterial Resistance Predicts the Course of Renal Function in Type 2 Diabetes With Microalbuminuria. Diabetes 55: 234-239 [Abstract] [Full Text]  
• Araki, S.-i., Haneda, M., Sugimoto, T., Isono, M., Isshiki, K., Kashiwagi, A., Koya, D. (2005). Factors Associated With Frequent Remission of Microalbuminuria in Patients With Type 2 Diabetes. Diabetes 54: 2983-2987 [Abstract] [Full Text]  
• Qi, Z., Fujita, H., Jin, J., Davis, L. S., Wang, Y., Fogo, A. B., Breyer, M. D. (2005). Characterization of Susceptibility of Inbred Mouse Strains to Diabetic Nephropathy. Diabetes 54: 2628-2637 [Abstract] [Full Text]  
• Forbes, J. M., Thorpe, S. R., Thallas-Bonke, V., Pete, J., Thomas, M. C., Deemer, E. R., Bassal, S., El-Osta, A., Long, D. M., Panagiotopoulos, S., Jerums, G., Osicka, T. M., Cooper, M. E. (2005). Modulation of Soluble Receptor for Advanced Glycation End Products by Angiotensin-Converting Enzyme-1 Inhibition in Diabetic Nephropathy. J. Am. Soc. Nephrol. 16: 2363-2372 [Abstract] [Full Text]  
• Steinke, J. M., Sinaiko, A. R., Kramer, M. S., Suissa, S., Chavers, B. M., Mauer, M., for the International Diabetic Nephropathy Study G, (2005). The Early Natural History of Nephropathy in Type 1 Diabetes: III. Predictors of 5-Year Urinary Albumin Excretion Rate Patterns in Initially Normoalbuminuric Patients. Diabetes 54: 2164-2171 [Abstract] [Full Text]  
• Coppelli, A., Giannarelli, R., Vistoli, F., Del Prato, S., Rizzo, G., Mosca, F., Boggi, U., Marchetti, P. (2005). The Beneficial Effects of Pancreas Transplant Alone on Diabetic Nephropathy. Diabetes Care 28: 1366-1370 [Abstract] [Full Text]  
• Baskar, V., Kamalakannan, D., Kiberd, B., Holland, M.R., Singh, B.M. (2005). Hypertension-based clinical risk strategies for detecting microalbuminuria in diabetes. QJM 98: 427-433 [Abstract] [Full Text]  
• Wu, T.-L., Chang, P.-Y., Li, C.-C., Tsao, K.-C., Sun, C.-F., Wu, J. T. (2005). Microplate ELISA for Urine Microalbumin: Reference Values and Results in Patients with Type 2 Diabetes and Cardiovascular Disease. Annals of Clinical & Laboratory Science 35: 149-154 [Abstract] [Full Text]  
• Liu, Y., Burdon, K. P., Langefeld, C. D., Beck, S. R., Wagenknecht, L. E., Rich, S. S., Bowden, D. W., Freedman, B. I. (2005). T-786C Polymorphism of the Endothelial Nitric Oxide Synthase Gene Is Associated with Albuminuria in the Diabetes Heart Study. J. Am. Soc. Nephrol. 16: 1085-1090 [Abstract] [Full Text]  
• Vidt, D. G. (2005). Update in Nephrology and Hypertension. ANN INTERN MED 142: 433-438 [Full Text]  
• Krimholtz, M. J., Karalliedde, J., Thomas, S., Bilous, R., Viberti, G. (2005). Targeting Albumin Excretion Rate in the Treatment of the Hypertensive Diabetic Patient with Renal Disease. J. Am. Soc. Nephrol. 16: S42-S47 [Abstract] [Full Text]  
• Zandi-Nejad, K., Brenner, B. M., Mauer, M., Fioretto, P., Ruggenenti, P., Perna, A., Remuzzi, G. (2005). Preventing Microalbuminuria in Type 2 Diabetes. NEJM 352: 833-834 [Full Text]  
• Ibsen, H., Olsen, M. H., Wachtell, K., Borch-Johnsen, K., Lindholm, L. H., Mogensen, C. E., Dahlof, B., Devereux, R. B., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Lederballe-Pedersen, O., Nieminen, M. S., Omvik, P., Oparil, S., Wan, Y. (2005). Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202 [Abstract] [Full Text]  
• Perkins, B. A., Bril, V. (2005). Early Vascular Risk Factor Modification in Type 1 Diabetes. NEJM 352: 408-409 [Full Text]  
• Gross, J. L., de Azevedo, M. J., Silveiro, S. P., Canani, L. H., Caramori, M. L., Zelmanovitz, T. (2005). Diabetic Nephropathy: Diagnosis, Prevention, and Treatment. Diabetes Care 28: 164-176 [Abstract] [Full Text]  
• Silverstein, J., Klingensmith, G., Copeland, K., Plotnick, L., Kaufman, F., Laffel, L., Deeb, L., Grey, M., Anderson, B., Holzmeister, L. A., Clark, N. (2005). Care of Children and Adolescents With Type 1 Diabetes: A statement of the American Diabetes Association. Diabetes Care 28: 186-212 [Full Text]  
• Ruggenenti, P., Fassi, A., Ilieva, A. P., Bruno, S., Iliev, I. P., Brusegan, V., Rubis, N., Gherardi, G., Arnoldi, F., Ganeva, M., Ene-Iordache, B., Gaspari, F., Perna, A., Bossi, A., Trevisan, R., Dodesini, A. R., Remuzzi, G., the Bergamo Nephrologic Diabetes Complications Tri, (2004). Preventing Microalbuminuria in Type 2 Diabetes. NEJM 351: 1941-1951 [Abstract] [Full Text]  
• Hadjadj, S., Pean, F., Gallois, Y., Passa, P., Aubert, R., Weekers, L., Rigalleau, V., Bauduceau, B., Bekherraz, A., Roussel, R., Dussol, B., Rodier, M., Marechaud, R., Lefebvre, P. J., Marre, M., for the Genesis France-Belgium Study, (2004). Different Patterns of Insulin Resistance in Relatives of Type 1 Diabetic Patients With Retinopathy or Nephropathy: The Genesis France-Belgium Study. Diabetes Care 27: 2661-2668 [Abstract] [Full Text]  
• Marshall, S M (2004). Recent advances in diabetic nephropathy. Postgrad. Med. J. 80: 624-633 [Abstract] [Full Text]  
• Sowers, J. R. (2004). Treatment of Hypertension in Patients With Diabetes. Arch Intern Med 164: 1850-1857 [Abstract] [Full Text]  
• Harjutsalo, V., Katoh, S., Sarti, C., Tajima, N., Tuomilehto, J. (2004). Population-Based Assessment of Familial Clustering of Diabetic Nephropathy in Type 1 Diabetes. Diabetes 53: 2449-2454 [Abstract] [Full Text]  
• (2004). Polyunsaturated Fatty Acid Consumption May Play a Role in the Onset and Regression of Microalbuminuria in Well-Controlled Type 1 and Type 2 Diabetic People: A 7-year, prospective, population-based, observational multicenter study. Diabetes Care 27: 1454-1457 [Full Text]  
• Hovind, P., Tarnow, L., Rossing, P., Jensen, B. R., Graae, M., Torp, I., Binder, C., Parving, H.-H. (2004). Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 328: 1105- [Abstract] [Full Text]  
• Svensson, M., Eriksson, J. W., Dahlquist, G. (2004). Early Glycemic Control, Age at Onset, and Development of Microvascular Complications in Childhood-Onset Type 1 Diabetes: A population-based study in northern Sweden. Diabetes Care 27: 955-962 [Abstract] [Full Text]  
• Larsen, J. R., Sjoholm, H., Berg, T. J., Sandvik, L., Brekke, M., Hanssen, K. F., Dahl-Jorgensen, K. (2004). Eighteen Years of Fair Glycemic Control Preserves Cardiac Autonomic Function in Type 1 Diabetes. Diabetes Care 27: 963-966 [Abstract] [Full Text]  
• Fetterolf, D., West, R. (2004). The Business Case for Quality: Combining Medical Literature Research with Health Plan Data to Establish Value for Nonclinical Managers. American Journal of Medical Quality 19: 48-55 [Abstract]  
• Susztak, K., Bottinger, E., Novetsky, A., Liang, D., Zhu, Y., Ciccone, E., Wu, D., Dunn, S., McCue, P., Sharma, K. (2004). Molecular Profiling of Diabetic Mouse Kidney Reveals Novel Genes Linked to Glomerular Disease. Diabetes 53: 784-794 [Abstract] [Full Text]  
• Lane, J. T. (2004). Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective. Am. J. Physiol. Renal Physiol. 286: F442-F450 [Abstract] [Full Text]  
• Pettersson-Fernholm, K., Karvonen, M. K., Kallio, J., Forsblom, C. M., Koulu, M., Pesonen, U., Fagerudd, J. A., Groop, P.-H. (2004). Leucine 7 to Proline 7 Polymorphism in the Preproneuropeptide Y Is Associated With Proteinuria, Coronary Heart Disease, and Glycemic Control in Type 1 Diabetic Patients. Diabetes Care 27: 503-509 [Abstract] [Full Text]  
• Bloomgarden, Z. T. (2004). Aspects of Blood Pressure, Lipid, and Glycemic Treatment. Diabetes Care 27: 264-269 [Full Text]  
• P.K. Ng, D., Chia, K.-S., Koh, D. (2004). Phenotypic Heterogeneity and Associations of Two Aldose Reductase Gene Polymorphisms With Nephropathy and Retinopathy in Type 2 Diabetes: Response to Wang et al.. Diabetes Care 27: 289-290 [Full Text]  
• Duggirala, M. K., Mundell, W. C., Mikkilineni, P., Aziz, I., Garrido, J. A., Roberts, C. K., Barnard, R. J., Samaha, F. F., Stern, L., Iqbal, N., Foster, G. D., Hill, J. O., Klein, S. (2003). Low-Carbohydrate Diets as Compared with Low-Fat Diets. NEJM 349: 1000-1002 [Full Text]  
• Freedman, B. I., Beck, S. R., Rich, S. S., Heiss, G., Lewis, C. E., Turner, S., Province, M. A., Schwander, K. L., Arnett, D. K., Mellen, B. G. (2003). A Genome-Wide Scan for Urinary Albumin Excretion in Hypertensive Families. Hypertension 42: 291-296 [Abstract] [Full Text]  
• Friedman, A. N., Catena, C., Novello, M., Sechi, L. A., Hohenadel, D., Bode, H., van der Woude, F. J., Zerbini, G., Perkins, B. A., Warram, J. H., Krolewski, A. S. (2003). Regression of Microalbuminuria in Type 1 Diabetes. NEJM 349: 906-908 [Full Text]  
• (2003). Microalbuminuria Can Regress in Diabetic Patients. Journal Watch Cardiology 2003: 8-8 [Full Text]  
• (2003). Microalbuminuria Can Regress in Diabetic Patients. JWatch General 2003: 1-1 [Full Text]  
• Ritz, E. (2003). Albuminuria and Vascular Damage -- The Vicious Twins. NEJM 348: 2349-2352 [Full Text]